Prostaglandin E2 as a Mechanistic Biomarker of Chronic Pancreatitis
While PGE2 is detectable in pancreas fluid, these data suggest that it may not be sensitive enough to distinguish between AP/RAP and CP. However, MMPs may distinguish between stages of pancreatitis and require further testing as potential diagnostic biomarkers.
Authors
- Santhi Swaroop Vege (ORCID: https://orcid.org/0000-0002-5742-2963)
- Phil A. Hart
- Darwin L. Conwell (ORCID: https://orcid.org/0000-0003-0449-3730)
- Dhiraj Yadav (ORCID: https://orcid.org/0000-0001-7078-9893)
- Evan L. Fogel (ORCID: https://orcid.org/0000-0003-0998-8257)
- Mark Topazian (ORCID: https://orcid.org/0000-0003-1090-2844)
- Samuel Han (ORCID: https://orcid.org/0000-0001-7373-7984)
- Walter G. Park (ORCID: https://orcid.org/0000-0001-8187-4188)
- Jami L. Saloman (ORCID: https://orcid.org/0000-0001-6093-6511)
- Bahiyyah Jefferson
- Liang Li (ORCID: https://orcid.org/0000-0001-5453-3839)
- William E. Fisher
Institutions
- Mayo Clinic (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Kentucky (US)
- University of Pittsburgh (US)
- Baylor College of Medicine (US)
- University of Washington (US)
- WinnMed (US)
- The Ohio State University Wexner Medical Center (US)
- Pain Management Institute (US)
- Mayo Clinic in Arizona (US)
- Indiana University – Purdue University Indianapolis (US)
- Stanford University (US)
Publication Details
- Journal
- Clinical and Translational Gastroenterology
- Published
- 2025-08-04
- DOI
- https://doi.org/10.14309/ctg.0000000000000897
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00